Haloperidol Tablets

Healthy Inc is a specialized global supplier and exporter of high-potency typical antipsychotics. We provide high-purity Haloperidol Tablets, sourced from WHO–GMP certified solid dosage facilities. This “First-Generation” neuroleptic is a top export to psychiatric hospitals, prison formularies, and government mental health tenders in Africa, LATAM, and Southeast Asia, serving as the gold standard for the rapid management of acute psychosis, agitation, and severe behavioral disorders.


Product Overview

This formulation contains Haloperidol, a butyrophenone derivative.

The “Dopamine Blocker” Specialist:

  • High Potency: Haloperidol is a “high-potency” antipsychotic. It exerts strong clinical effects at low milligram doses (compared to Chlorpromazine which requires hundreds of milligrams).
  • Mechanism: It acts by strongly blocking postsynaptic Dopamine D2 receptors in the mesolimbic system of the brain. This effectively suppresses “positive symptoms” of schizophrenia such as hallucinations, delusions, and disorganized thinking.
  • Agitation Control: It has a pronounced sedative effect in acute mania or severe agitation, making it a critical drug for emergency psychiatry (often called “chemical restraint”).
  • Tourette’s Control: It blocks dopamine receptors in the basal ganglia, reducing the motor and phonic tics associated with Tourette’s Syndrome.

Product Composition & Strength

We supply this product as Uncoated Tablets (often small, white or yellow). We offer a wide range of strengths for precise titration.

Active Ingredient Strength (Standard) Primary Role
Haloperidol USP/BP 1.5 mg Geriatric / Maintenance
Haloperidol USP/BP 5 mg Standard Acute Dose
Haloperidol USP/BP 10 mg Severe Psychosis / Mania
Haloperidol USP/BP 20 mg Treatment Resistant Cases

*Pack Sizes: Blister packs of 10s (Box of 10×10), 50s, or Bulk HDPE Jars of 500s/1000s (Institutional Packs).


Technical & Logistics Specifications

Critical data for Pharmaceutical Importers and Distributors.

HS Code 3004.90.99 (Other Medicaments)
Dosage Form Tablet (Oral)
Packaging PVC-Alu Blister or Alu-Alu Blister
Storage Store below 25°C. Protect from light.
Certificates WHO-GMP, COPP, Free Sale Certificate

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

  • Dose Uniformity: The 1.5 mg tablet requires precise geometric blending during manufacturing to ensure content uniformity. We use validated mixing protocols to prevent dose variation in these potent, low-dose tablets.
  • Stability: Haloperidol is sensitive to light. Our formulation includes UV-stabilizing excipients and opaque packaging to prevent degradation (which turns the tablet yellow/brown).

Therapeutic Indications (Human Use)

Indicated for the management of psychotic disorders:

  • Schizophrenia: Acute and maintenance treatment of schizophrenia and psychotic disorders.
  • Acute Mania: Manic episodes associated with Bipolar I Disorder.
  • Tourette’s Disorder: Control of tics and vocalizations in children and adults.
  • Severe Behavioral Problems: In children with combative, explosive hyperexcitability (short-term use).

Dosage & Administration

Recommended Dosage (Strictly as per Psychiatrist):

  • Route: Oral.
  • Moderate Symptoms: 0.5 mg to 2 mg taken 2 or 3 times daily.
  • Severe Symptoms: 3 mg to 5 mg taken 2 or 3 times daily. Max 30 mg/day (rarely higher).
  • Geriatric (Elderly): Start very low (0.5 mg to 1.5 mg) due to high risk of side effects.
  • Maintenance: Once symptoms are controlled, the dose should be gradually reduced to the lowest effective level.

Safety Warnings:

  • Extrapyramidal Symptoms (EPS): Very common. Includes dystonia (muscle spasms), parkinsonism (tremors/rigidity), and akathisia (severe restlessness). Often requires co-administration of an anticholinergic (e.g., Trihexyphenidyl).
  • Tardive Dyskinesia: Long-term use can cause irreversible involuntary movements of the face and tongue.
  • Neuroleptic Malignant Syndrome (NMS): A rare but fatal reaction (high fever, rigid muscles). Immediate discontinuation required.
  • QT Prolongation: Can cause heart arrhythmias. Monitor ECG in heart patients.
  • Black Box Warning (Dementia): Increased risk of death in elderly patients with dementia-related psychosis.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for OSD (Oral Solid Dosage) forms, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for government procurement in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.

Commercial Inquiries

For hospital tenders, bulk export, or distributor pricing, please contact our export team.

WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in

Add to cart